WithdrawnPhase 4

Misoprostol in Office Hysteroscopy and Endometrial Biopsy

Stopped: Unable to get patients interested in the study

United States0Started 2018-09-01

Plain-language summary

We hypothesize that use of vaginal misoprostol will help in reducing the pain scores when used prior to concurrent office hysteroscopy and endometrial biopsy in a particular subgroup of women who are anticipated to require cervical dilatation.

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All consecutive female patients aged 18-70 years presenting to the Center for successive OH and EMB with the ability to provide written informed consent and meets at least one of the criteria mentioned below: * Previous cesarean section * Nulliparous * Postmenopausal * Previous loop electrosurgical excision procedure (LEEP) or cone biopsy * Previous myomectomy Exclusion Criteria: Premenopausal multiparous women with no prior surgeries performed on the uterus. * Patients unable to provide informed consent * Patients visiting the fibroid and endometriosis center with abnormal uterine bleeding, infertility or for preoperative evaluation; however, OH and EMB is not required for their evaluation based on their providers' clinical judgment. * Patients with genital tract lesions.

What they're measuring

Pain score recorded in VAS

Timeframe: Day of procedure

Trial details

NCT IDNCT03547778

SponsorUniversity of South Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-31

View on ClinicalTrials.gov More Office Hysteroscopy and Endometrial Biopsy trials